Trial intelligence / Profile preview

Clonazepam for reduction of anxiety

IRCT201012195420N1Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Dec 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of clonazepam in anxiety disorder, sponsored by Shiraz University of Medical Sciences. Started Dec 2010; status: completed.

02

Drugs

clonazepam
03

Conditions

anxiety disorder

Beyond the preview

Go deeper on IRCT201012195420N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201012195420N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call